Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v5-EN | Version v3-EN | |
---|---|---|
Language | English | English |
Date Updated | 2020-10-19 | 2020-09-28 |
Drug Identification Number | 02242528 | 02242528 |
Brand name | SANDOZ PROCTOMYXIN HC SUPPOSITORIES | SANDOZ PROCTOMYXIN HC SUPPOSITORIES |
Common or Proper name | SANDOZ PROCTOMYXIN HC SUPPOSITOIRES | SANDOZ PROCTOMYXIN HC SUPPOSITOIRES |
Company Name | ODAN LABORATORIES LTD | ODAN LABORATORIES LTD |
Ingredients | DIBUCAINE HYDROCHLORIDE ESCULIN HYDROCORTISONE FRAMYCETIN SULFATE | DIBUCAINE HYDROCHLORIDE ESCULIN HYDROCORTISONE FRAMYCETIN SULFATE |
Strength(s) | 5MG 10MG 5MG 10MG | 5MG 10MG 5MG 10MG |
Dosage form(s) | SUPPOSITORY | SUPPOSITORY |
Route of administration | RECTAL RECTAL | RECTAL RECTAL |
Packaging size | 12SUP ST V1 CA | 12SUP ST V1 CA |
ATC code | C05AA | C05AA |
ATC description | AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE | AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE |
Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
Anticipated start date | ||
Actual start date | 2020-09-11 | 2020-09-11 |
Estimated end date | 2020-10-16 | 2020-10-16 |
Actual end date | 2020-10-16 | |
Shortage status | Resolved | Actual shortage |
Tier 3 Status | No | No |
Company comments | ||
Health Canada comments |